Product NDC: | 54868-1334 |
Proprietary Name: | Carbidopa and Levodopa |
Non Proprietary Name: | Carbidopa and Levodopa |
Active Ingredient(s): | 25; 100 mg/1; mg/1 & nbsp; Carbidopa and Levodopa |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-1334 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073589 |
Marketing Category: | ANDA |
Start Marketing Date: | 19941209 |
Package NDC: | 54868-1334-7 |
Package Description: | 120 TABLET in 1 BOTTLE (54868-1334-7) |
NDC Code | 54868-1334-7 |
Proprietary Name | Carbidopa and Levodopa |
Package Description | 120 TABLET in 1 BOTTLE (54868-1334-7) |
Product NDC | 54868-1334 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carbidopa and Levodopa |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19941209 |
Marketing Category Name | ANDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | CARBIDOPA; LEVODOPA |
Strength Number | 25; 100 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |